Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Conditions
- Transplantation, Homologous
- Transplantation, Autologous
- Multiple Myeloma
- Blood and Marrow Transplant (BMT)
Interventions
- PROCEDURE: Autologous peripheral blood stem cells (auto-PBSC) transplantation
- PROCEDURE: Allogeneic peripheral blood stem cells (allo-PBSC) transplantation
- DRUG: Filgrastim
- DRUG: Cyclophosphamide
- DRUG: Melphalan
- DRUG: Cyclosporine
- RADIATION: Total lymphoid irradiation
- BIOLOGICAL: Rabbit anti-thymocyte globulin
- DRUG: Mycophenolate Mofetil 250mg
- DRUG: Solumedrol
- DRUG: Diphenhydramine
- DRUG: Acetaminophen
- DRUG: Hydrocortisone
Sponsor
Stanford University